Table 2 Incident Rate Ratio (IRR) of the incidence of hospitalisations, respiratory exacerbations and prescribed antimicrobials between cohorts

PA vs Clear

1.00 (0.44, 2.30)

1

0.76 (0.37, 1.55)

1

1.19 (0.93, 1.51)

0.259

PAp vs Clear

1.89 (1.11, 3.22)

0.004

1.91 (1.19, 3.05)

<0.001

1.55 (1.29, 1.86)

<0.001

AF vs Clear

1.16 (0.54, 2.48)

1

0.95 (0.45, 1.98)

1

1.63 (1.19, 2.21)

<0.001

AFp vs Clear

1.97 (0.75, 5.20)

0.271

1.59 (0.74, 3.44)

0.494

1.9 (1.38, 2.62)

<0.001

AF + PA vs Clear

2.65 (1.01, 6.97)

0.023

2.12 (0.95, 4.72)

0.042

1.48 (1.04, 2.11)

0.009

PA vs PAp

0.53 (0.23, 1.23)

0.189

0.4 (0.19, 0.81)

0.001

0.77 (0.60, 0.98)

0.014

AF vs Afp

0.59 (0.21, 1.67)

0.872

0.59 (0.24, 1.47)

0.775

0.86 (0.56, 1.30)

1

AF + PA vs PA

0.38 (0.12, 1.21)

0.099

0.36 (0.13, 0.95)

0.015

0.8 (0.54, 1.19)

0.668

AF + PA vs PAp

1.40 (0.53, 3.73)

1

1.11 (0.51, 2.43)

1

0.96 (0.66, 1.38)

1

AF + PA vs AF

0.45 (0.15, 1.33)

0.209

0.47 (0.17, 1.31)

0.205

1.09 (0.69, 1.74)

1

AF + PA vs AFp

1.30 (0.38, 4.44)

1

0.79 (0.28, 2.21)

1

0.78 (0.49, 1.25)

0.8